LeadIQ logo
Learn more at LeadIQ.com
Keros Therapeutics logo

Keros Therapeutics Employee Directory

Biotechnology ResearchMassachusetts, United States51-200 Employees

Keros Therapeutics has about 122 employees across 2 continents, most of them in North America. Biotechnology and Legal make up over half of the profiles with a known department. Keros Therapeutics's workforce spans 20 departments. Keros Therapeutics's workforce fell 32% between July 2025 and July 2026.

Find Keros Therapeutics employees' phone numbers or email addresses

Keros Therapeutics Global Highlights

Location
Employees

North America
138

Minus sign iconPlus sign icon
  • United States Of America
    138

Africa
2

Minus sign iconPlus sign icon
  • Ethiopia
    1
  • Angola
    1

Asia
1

Minus sign iconPlus sign icon
  • India
    1

Europe
1

Minus sign iconPlus sign icon
  • Denmark
    1

South America
1

Minus sign iconPlus sign icon
  • Brazil
    1

North America accounts for 97% of Keros Therapeutics's workforce, followed by Africa (1%).

Keros Therapeutics's Leadership

  • Chief Executive Officer And Director at Keros Therapeutics
    J. S.
    Chief Executive Officer And Director
    Mobile Phone
  • Chief Scientific Officer at Keros Therapeutics
    J. L.
    Chief Scientific Officer
    Mobile Phone
  • Clinical Project Manager at Keros Therapeutics
    K. O.
    Clinical Project Manager
    Mobile Phone
  • Associate Director at Keros Therapeutics
    B. X.
    Associate Director
    Mobile Phone
  • Principal Medical Writer at Keros Therapeutics
    J. S.
    Principal Medical Writer
    Mobile Phone
  • Non Executive Board Member at Keros Therapeutics
    A. P.
    Non Executive Board Member
    Mobile Phone
  • Cmc Analytical Co-Op at Keros Therapeutics
    R. K.
    Cmc Analytical Co-Op
    Mobile Phone
  • Research Associate Intern at Keros Therapeutics
    D. B.
    Research Associate Intern
    Mobile Phone

Keros Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Quality Assurance
  • Program & Project Management
  • Accounting
  • Operations
  • Other
  • Engineering
  • Biotechnology
  • Legal
  • Business
  • Entrepreneurship

Biotechnology is the largest department at 42% of profiles with a known department, up from 0% in July 2025, followed by Legal (13%, up from 3%) and Accounting (8%, up from 5%).

Contact profiles from Keros Therapeutics

Name
Title
Contact
Location
Last Update
  • Chief Executive Officer And Director at Keros Therapeutics
    J. S.
    Chief Executive Officer And Director
    Mobile Phone
    Oct 23, 2024
  • Chief Scientific Officer at Keros Therapeutics
    J. L.
    Chief Scientific Officer
    Mobile Phone
    Jun 04, 2025
  • Clinical Project Manager at Keros Therapeutics
    K. O.
    Clinical Project Manager
    Mobile Phone
    Sep 18, 2026
  • Associate Director at Keros Therapeutics
    B. X.
    Associate Director
    Mobile Phone
    May 09, 2025
  • Principal Medical Writer at Keros Therapeutics
    J. S.
    Principal Medical Writer
    Mobile Phone
    Oct 22, 2024
  • Non Executive Board Member at Keros Therapeutics
    A. P.
    Non Executive Board Member
    Mobile Phone
    Denmark
    Aug 12, 2026
  • Cmc Analytical Co-Op at Keros Therapeutics
    R. K.
    Cmc Analytical Co-Op
    Mobile Phone
    Oct 08, 2026
  • Research Associate Intern at Keros Therapeutics
    D. B.
    Research Associate Intern
    Mobile Phone
    Sep 11, 2026

Frequently Asked Questions

What are the largest departments at Keros Therapeutics?

Minus sign iconPlus sign iconBiotechnology is the largest department at 42% of profiles with a known department, up from 0% in July 2025, followed by Legal (13%, up from 3%) and Accounting (8%, up from 5%). Keros Therapeutics's workforce spans 20 departments.

Where are Keros Therapeutics's employees located?

Minus sign iconPlus sign iconKeros Therapeutics has about 122 employees across 2 continents, most of them in North America. North America accounts for 97% of Keros Therapeutics's workforce, followed by Africa (1%).

How has Keros Therapeutics's workforce changed over the past year?

Minus sign iconPlus sign iconKeros Therapeutics's workforce fell 32% between July 2025 and July 2026. Biotechnology's share of profiles with a known department rose from 0% to 42%.

How many employees does Keros Therapeutics have currently?

Minus sign iconPlus sign iconKeros Therapeutics has approximately 122 employees as of October 2026. These team members are located across 5 continents, including North America, Africa and Asia.

Who are Keros Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of October 2026, Keros Therapeutics's key employees include:

  • Chief Executive Officer And Director: J. S.
  • Chief Scientific Officer: J. L.
  • Clinical Project Manager: K. O.
  • Associate Director: B. X.
  • Principal Medical Writer: J. S.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

What is Keros Therapeutics's most common email format?

Minus sign iconPlus sign iconKeros Therapeutics employees' email format typically follows the pattern of FLast@kerostx.com. Trying to find reliable and up-to-date employee contact data? Find more Keros Therapeutics email formats with LeadIQ.

What is Keros Therapeutics known for?

Minus sign iconPlus sign iconKeros Therapeutics was founded in 2016 and operates in the Biotechnology Research industry. You can contact Keros Therapeutics's main corporate office by phone at
+1-617-314-****
. Explore Keros Therapeutics's company overview page for more information.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

  • B2B data verified in real-time
  • Sync data to your CRM, & add it to an outreach sequence in one click
  • Integrations with your tech stack for optimal efficiency
  • A patented AI cold email generator
  • Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.